Amatuximab ELISA Kit

Description of Amatuximab ELISA Kit

Amatuximab ELISA Kit is a highly sensitive and specific diagnostic tool used for the detection and quantification of Amatuximab, a monoclonal antibody targeting the mesothelin protein. This kit is designed for research purposes and is not intended for diagnostic or therapeutic use.

Amatuximab is a chimeric IgG1 monoclonal antibody, composed of both human and murine components. It has a molecular weight of approximately 150 kDa and consists of two heavy chains and two light chains. The heavy chains are comprised of four constant domains (CH1, CH2, CH3, and CH4) and one variable domain (VH), while the light chains contain two constant domains (CL and CL1) and one variable domain (VL). The variable domains are responsible for binding to the mesothelin protein.

Amatuximab specifically targets the mesothelin protein, which is overexpressed in various types of cancer, including mesothelioma, ovarian cancer, and pancreatic cancer. The binding of Amatuximab to mesothelin inhibits its interaction with other proteins, leading to a decrease in cell proliferation, invasion, and migration. In addition, Amatuximab also induces antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC), which further contribute to its anti-tumor activity.

The Amatuximab ELISA Kit is a valuable tool for researchers studying the mesothelin protein and its role in cancer. It allows for the accurate quantification of Amatuximab levels in various biological samples, such as serum, plasma, and cell culture supernatant. This information can be used to monitor the pharmacokinetics and pharmacodynamics of Amatuximab in preclinical and clinical studies.

Moreover, the Amatuximab ELISA Kit can also be used to measure the levels of endogenous mesothelin in cancer patients. Elevated levels of mesothelin have been associated with poor prognosis and disease progression in various types of cancer. Therefore, the Amatuximab ELISA Kit can aid in the diagnosis and monitoring of mesothelin-positive cancers.

In addition, this kit can be used for the screening and characterization of potential therapeutic antibodies targeting mesothelin. By measuring the binding affinity and specificity of these antibodies, the Amatuximab ELISA Kit can help in the development of novel and more effective anti-cancer therapies.

In summary, the Amatuximab ELISA Kit is a powerful tool for the detection and quantification of Amatuximab, a monoclonal antibody targeting the mesothelin protein. Its high sensitivity and specificity make it a valuable resource for researchers studying the role of mesothelin in cancer and for the development of novel anti-cancer therapies. With its accurate and reliable results, the Amatuximab ELISA Kit is an essential tool in the field of cancer research.